Global Daunorubicin Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0? or 37? for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.
LPI (LP Information)' newest research report, the “Daunorubicin Industry Forecast” looks at past sales and reviews total world Daunorubicin sales in 2022, providing a comprehensive analysis by region and market sector of projected Daunorubicin sales for 2023 through 2029. With Daunorubicin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Daunorubicin industry.
This Insight Report provides a comprehensive analysis of the global Daunorubicin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Daunorubicin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Daunorubicin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Daunorubicin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Daunorubicin.
The global Daunorubicin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Daunorubicin players cover Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia and Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Daunorubicin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Daunorubicin market?
What factors are driving Daunorubicin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Daunorubicin market opportunities vary by end market size?
How does Daunorubicin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0? or 37? for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.
LPI (LP Information)' newest research report, the “Daunorubicin Industry Forecast” looks at past sales and reviews total world Daunorubicin sales in 2022, providing a comprehensive analysis by region and market sector of projected Daunorubicin sales for 2023 through 2029. With Daunorubicin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Daunorubicin industry.
This Insight Report provides a comprehensive analysis of the global Daunorubicin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Daunorubicin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Daunorubicin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Daunorubicin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Daunorubicin.
The global Daunorubicin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Daunorubicin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Daunorubicin players cover Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia and Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Daunorubicin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Intravenous
- Drip
- Acute Granulocyte
- Acute Lymphocyte Leukemia
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Halison Pharmaceuiticals
- Hikma Pharmaceuticals
- Gilead Sciences
- Bedford Pharmaceuticals
- United Biotech
- Mercian Corporation
- Pharmacia
- Cipla
- TEVA
- Medior Healthcare
- West-Ward
- Shandong Xinshidai Pharmaceutical
- HISUN
- Shenzhen Wanle Pharmaceutical
What is the 10-year outlook for the global Daunorubicin market?
What factors are driving Daunorubicin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Daunorubicin market opportunities vary by end market size?
How does Daunorubicin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Daunorubicin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Daunorubicin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Daunorubicin by Country/Region, 2018, 2022 & 2029
2.2 Daunorubicin Segment by Type
2.2.1 Intravenous
2.2.2 Drip
2.3 Daunorubicin Sales by Type
2.3.1 Global Daunorubicin Sales Market Share by Type (2018-2023)
2.3.2 Global Daunorubicin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Daunorubicin Sale Price by Type (2018-2023)
2.4 Daunorubicin Segment by Application
2.4.1 Acute Granulocyte
2.4.2 Acute Lymphocyte Leukemia
2.5 Daunorubicin Sales by Application
2.5.1 Global Daunorubicin Sale Market Share by Application (2018-2023)
2.5.2 Global Daunorubicin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Daunorubicin Sale Price by Application (2018-2023)
3 GLOBAL DAUNORUBICIN BY COMPANY
3.1 Global Daunorubicin Breakdown Data by Company
3.1.1 Global Daunorubicin Annual Sales by Company (2018-2023)
3.1.2 Global Daunorubicin Sales Market Share by Company (2018-2023)
3.2 Global Daunorubicin Annual Revenue by Company (2018-2023)
3.2.1 Global Daunorubicin Revenue by Company (2018-2023)
3.2.2 Global Daunorubicin Revenue Market Share by Company (2018-2023)
3.3 Global Daunorubicin Sale Price by Company
3.4 Key Manufacturers Daunorubicin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Daunorubicin Product Location Distribution
3.4.2 Players Daunorubicin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DAUNORUBICIN BY GEOGRAPHIC REGION
4.1 World Historic Daunorubicin Market Size by Geographic Region (2018-2023)
4.1.1 Global Daunorubicin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Daunorubicin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Daunorubicin Market Size by Country/Region (2018-2023)
4.2.1 Global Daunorubicin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Daunorubicin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Daunorubicin Sales Growth
4.4 APAC Daunorubicin Sales Growth
4.5 Europe Daunorubicin Sales Growth
4.6 Middle East & Africa Daunorubicin Sales Growth
5 AMERICAS
5.1 Americas Daunorubicin Sales by Country
5.1.1 Americas Daunorubicin Sales by Country (2018-2023)
5.1.2 Americas Daunorubicin Revenue by Country (2018-2023)
5.2 Americas Daunorubicin Sales by Type
5.3 Americas Daunorubicin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Daunorubicin Sales by Region
6.1.1 APAC Daunorubicin Sales by Region (2018-2023)
6.1.2 APAC Daunorubicin Revenue by Region (2018-2023)
6.2 APAC Daunorubicin Sales by Type
6.3 APAC Daunorubicin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Daunorubicin by Country
7.1.1 Europe Daunorubicin Sales by Country (2018-2023)
7.1.2 Europe Daunorubicin Revenue by Country (2018-2023)
7.2 Europe Daunorubicin Sales by Type
7.3 Europe Daunorubicin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Daunorubicin by Country
8.1.1 Middle East & Africa Daunorubicin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Daunorubicin Revenue by Country (2018-2023)
8.2 Middle East & Africa Daunorubicin Sales by Type
8.3 Middle East & Africa Daunorubicin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daunorubicin
10.3 Manufacturing Process Analysis of Daunorubicin
10.4 Industry Chain Structure of Daunorubicin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Daunorubicin Distributors
11.3 Daunorubicin Customer
12 WORLD FORECAST REVIEW FOR DAUNORUBICIN BY GEOGRAPHIC REGION
12.1 Global Daunorubicin Market Size Forecast by Region
12.1.1 Global Daunorubicin Forecast by Region (2024-2029)
12.1.2 Global Daunorubicin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Daunorubicin Forecast by Type
12.7 Global Daunorubicin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Daunorubicin Product Portfolios and Specifications
13.1.3 Sanofi Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Halison Pharmaceuiticals
13.2.1 Halison Pharmaceuiticals Company Information
13.2.2 Halison Pharmaceuiticals Daunorubicin Product Portfolios and Specifications
13.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Halison Pharmaceuiticals Main Business Overview
13.2.5 Halison Pharmaceuiticals Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Daunorubicin Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Gilead Sciences
13.4.1 Gilead Sciences Company Information
13.4.2 Gilead Sciences Daunorubicin Product Portfolios and Specifications
13.4.3 Gilead Sciences Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gilead Sciences Main Business Overview
13.4.5 Gilead Sciences Latest Developments
13.5 Bedford Pharmaceuticals
13.5.1 Bedford Pharmaceuticals Company Information
13.5.2 Bedford Pharmaceuticals Daunorubicin Product Portfolios and Specifications
13.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bedford Pharmaceuticals Main Business Overview
13.5.5 Bedford Pharmaceuticals Latest Developments
13.6 United Biotech
13.6.1 United Biotech Company Information
13.6.2 United Biotech Daunorubicin Product Portfolios and Specifications
13.6.3 United Biotech Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 United Biotech Main Business Overview
13.6.5 United Biotech Latest Developments
13.7 Mercian Corporation
13.7.1 Mercian Corporation Company Information
13.7.2 Mercian Corporation Daunorubicin Product Portfolios and Specifications
13.7.3 Mercian Corporation Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mercian Corporation Main Business Overview
13.7.5 Mercian Corporation Latest Developments
13.8 Pharmacia
13.8.1 Pharmacia Company Information
13.8.2 Pharmacia Daunorubicin Product Portfolios and Specifications
13.8.3 Pharmacia Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pharmacia Main Business Overview
13.8.5 Pharmacia Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Daunorubicin Product Portfolios and Specifications
13.9.3 Cipla Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 TEVA
13.10.1 TEVA Company Information
13.10.2 TEVA Daunorubicin Product Portfolios and Specifications
13.10.3 TEVA Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 TEVA Main Business Overview
13.10.5 TEVA Latest Developments
13.11 Medior Healthcare
13.11.1 Medior Healthcare Company Information
13.11.2 Medior Healthcare Daunorubicin Product Portfolios and Specifications
13.11.3 Medior Healthcare Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medior Healthcare Main Business Overview
13.11.5 Medior Healthcare Latest Developments
13.12 West-Ward
13.12.1 West-Ward Company Information
13.12.2 West-Ward Daunorubicin Product Portfolios and Specifications
13.12.3 West-Ward Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 West-Ward Main Business Overview
13.12.5 West-Ward Latest Developments
13.13 Shandong Xinshidai Pharmaceutical
13.13.1 Shandong Xinshidai Pharmaceutical Company Information
13.13.2 Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolios and Specifications
13.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Xinshidai Pharmaceutical Main Business Overview
13.13.5 Shandong Xinshidai Pharmaceutical Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Daunorubicin Product Portfolios and Specifications
13.14.3 HISUN Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
13.15 Shenzhen Wanle Pharmaceutical
13.15.1 Shenzhen Wanle Pharmaceutical Company Information
13.15.2 Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolios and Specifications
13.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shenzhen Wanle Pharmaceutical Main Business Overview
13.15.5 Shenzhen Wanle Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Daunorubicin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Daunorubicin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Daunorubicin by Country/Region, 2018, 2022 & 2029
2.2 Daunorubicin Segment by Type
2.2.1 Intravenous
2.2.2 Drip
2.3 Daunorubicin Sales by Type
2.3.1 Global Daunorubicin Sales Market Share by Type (2018-2023)
2.3.2 Global Daunorubicin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Daunorubicin Sale Price by Type (2018-2023)
2.4 Daunorubicin Segment by Application
2.4.1 Acute Granulocyte
2.4.2 Acute Lymphocyte Leukemia
2.5 Daunorubicin Sales by Application
2.5.1 Global Daunorubicin Sale Market Share by Application (2018-2023)
2.5.2 Global Daunorubicin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Daunorubicin Sale Price by Application (2018-2023)
3 GLOBAL DAUNORUBICIN BY COMPANY
3.1 Global Daunorubicin Breakdown Data by Company
3.1.1 Global Daunorubicin Annual Sales by Company (2018-2023)
3.1.2 Global Daunorubicin Sales Market Share by Company (2018-2023)
3.2 Global Daunorubicin Annual Revenue by Company (2018-2023)
3.2.1 Global Daunorubicin Revenue by Company (2018-2023)
3.2.2 Global Daunorubicin Revenue Market Share by Company (2018-2023)
3.3 Global Daunorubicin Sale Price by Company
3.4 Key Manufacturers Daunorubicin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Daunorubicin Product Location Distribution
3.4.2 Players Daunorubicin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DAUNORUBICIN BY GEOGRAPHIC REGION
4.1 World Historic Daunorubicin Market Size by Geographic Region (2018-2023)
4.1.1 Global Daunorubicin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Daunorubicin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Daunorubicin Market Size by Country/Region (2018-2023)
4.2.1 Global Daunorubicin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Daunorubicin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Daunorubicin Sales Growth
4.4 APAC Daunorubicin Sales Growth
4.5 Europe Daunorubicin Sales Growth
4.6 Middle East & Africa Daunorubicin Sales Growth
5 AMERICAS
5.1 Americas Daunorubicin Sales by Country
5.1.1 Americas Daunorubicin Sales by Country (2018-2023)
5.1.2 Americas Daunorubicin Revenue by Country (2018-2023)
5.2 Americas Daunorubicin Sales by Type
5.3 Americas Daunorubicin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Daunorubicin Sales by Region
6.1.1 APAC Daunorubicin Sales by Region (2018-2023)
6.1.2 APAC Daunorubicin Revenue by Region (2018-2023)
6.2 APAC Daunorubicin Sales by Type
6.3 APAC Daunorubicin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Daunorubicin by Country
7.1.1 Europe Daunorubicin Sales by Country (2018-2023)
7.1.2 Europe Daunorubicin Revenue by Country (2018-2023)
7.2 Europe Daunorubicin Sales by Type
7.3 Europe Daunorubicin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Daunorubicin by Country
8.1.1 Middle East & Africa Daunorubicin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Daunorubicin Revenue by Country (2018-2023)
8.2 Middle East & Africa Daunorubicin Sales by Type
8.3 Middle East & Africa Daunorubicin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daunorubicin
10.3 Manufacturing Process Analysis of Daunorubicin
10.4 Industry Chain Structure of Daunorubicin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Daunorubicin Distributors
11.3 Daunorubicin Customer
12 WORLD FORECAST REVIEW FOR DAUNORUBICIN BY GEOGRAPHIC REGION
12.1 Global Daunorubicin Market Size Forecast by Region
12.1.1 Global Daunorubicin Forecast by Region (2024-2029)
12.1.2 Global Daunorubicin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Daunorubicin Forecast by Type
12.7 Global Daunorubicin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Daunorubicin Product Portfolios and Specifications
13.1.3 Sanofi Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Halison Pharmaceuiticals
13.2.1 Halison Pharmaceuiticals Company Information
13.2.2 Halison Pharmaceuiticals Daunorubicin Product Portfolios and Specifications
13.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Halison Pharmaceuiticals Main Business Overview
13.2.5 Halison Pharmaceuiticals Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Daunorubicin Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Gilead Sciences
13.4.1 Gilead Sciences Company Information
13.4.2 Gilead Sciences Daunorubicin Product Portfolios and Specifications
13.4.3 Gilead Sciences Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gilead Sciences Main Business Overview
13.4.5 Gilead Sciences Latest Developments
13.5 Bedford Pharmaceuticals
13.5.1 Bedford Pharmaceuticals Company Information
13.5.2 Bedford Pharmaceuticals Daunorubicin Product Portfolios and Specifications
13.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bedford Pharmaceuticals Main Business Overview
13.5.5 Bedford Pharmaceuticals Latest Developments
13.6 United Biotech
13.6.1 United Biotech Company Information
13.6.2 United Biotech Daunorubicin Product Portfolios and Specifications
13.6.3 United Biotech Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 United Biotech Main Business Overview
13.6.5 United Biotech Latest Developments
13.7 Mercian Corporation
13.7.1 Mercian Corporation Company Information
13.7.2 Mercian Corporation Daunorubicin Product Portfolios and Specifications
13.7.3 Mercian Corporation Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mercian Corporation Main Business Overview
13.7.5 Mercian Corporation Latest Developments
13.8 Pharmacia
13.8.1 Pharmacia Company Information
13.8.2 Pharmacia Daunorubicin Product Portfolios and Specifications
13.8.3 Pharmacia Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pharmacia Main Business Overview
13.8.5 Pharmacia Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Daunorubicin Product Portfolios and Specifications
13.9.3 Cipla Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 TEVA
13.10.1 TEVA Company Information
13.10.2 TEVA Daunorubicin Product Portfolios and Specifications
13.10.3 TEVA Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 TEVA Main Business Overview
13.10.5 TEVA Latest Developments
13.11 Medior Healthcare
13.11.1 Medior Healthcare Company Information
13.11.2 Medior Healthcare Daunorubicin Product Portfolios and Specifications
13.11.3 Medior Healthcare Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medior Healthcare Main Business Overview
13.11.5 Medior Healthcare Latest Developments
13.12 West-Ward
13.12.1 West-Ward Company Information
13.12.2 West-Ward Daunorubicin Product Portfolios and Specifications
13.12.3 West-Ward Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 West-Ward Main Business Overview
13.12.5 West-Ward Latest Developments
13.13 Shandong Xinshidai Pharmaceutical
13.13.1 Shandong Xinshidai Pharmaceutical Company Information
13.13.2 Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolios and Specifications
13.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Xinshidai Pharmaceutical Main Business Overview
13.13.5 Shandong Xinshidai Pharmaceutical Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Daunorubicin Product Portfolios and Specifications
13.14.3 HISUN Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
13.15 Shenzhen Wanle Pharmaceutical
13.15.1 Shenzhen Wanle Pharmaceutical Company Information
13.15.2 Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolios and Specifications
13.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shenzhen Wanle Pharmaceutical Main Business Overview
13.15.5 Shenzhen Wanle Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Daunorubicin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Daunorubicin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Drip
Table 5. Global Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 6. Global Daunorubicin Sales Market Share by Type (2018-2023)
Table 7. Global Daunorubicin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Daunorubicin Revenue Market Share by Type (2018-2023)
Table 9. Global Daunorubicin Sale Price by Type (2018-2023) & (US$/Litre)
Table 10. Global Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 11. Global Daunorubicin Sales Market Share by Application (2018-2023)
Table 12. Global Daunorubicin Revenue by Application (2018-2023)
Table 13. Global Daunorubicin Revenue Market Share by Application (2018-2023)
Table 14. Global Daunorubicin Sale Price by Application (2018-2023) & (US$/Litre)
Table 15. Global Daunorubicin Sales by Company (2018-2023) & (Litre)
Table 16. Global Daunorubicin Sales Market Share by Company (2018-2023)
Table 17. Global Daunorubicin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Daunorubicin Revenue Market Share by Company (2018-2023)
Table 19. Global Daunorubicin Sale Price by Company (2018-2023) & (US$/Litre)
Table 20. Key Manufacturers Daunorubicin Producing Area Distribution and Sales Area
Table 21. Players Daunorubicin Products Offered
Table 22. Daunorubicin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Daunorubicin Sales by Geographic Region (2018-2023) & (Litre)
Table 26. Global Daunorubicin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Daunorubicin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Daunorubicin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Daunorubicin Sales by Country/Region (2018-2023) & (Litre)
Table 30. Global Daunorubicin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Daunorubicin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Daunorubicin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 34. Americas Daunorubicin Sales Market Share by Country (2018-2023)
Table 35. Americas Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Daunorubicin Revenue Market Share by Country (2018-2023)
Table 37. Americas Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 38. Americas Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 39. APAC Daunorubicin Sales by Region (2018-2023) & (Litre)
Table 40. APAC Daunorubicin Sales Market Share by Region (2018-2023)
Table 41. APAC Daunorubicin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Daunorubicin Revenue Market Share by Region (2018-2023)
Table 43. APAC Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 44. APAC Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 45. Europe Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 46. Europe Daunorubicin Sales Market Share by Country (2018-2023)
Table 47. Europe Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Daunorubicin Revenue Market Share by Country (2018-2023)
Table 49. Europe Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 50. Europe Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 51. Middle East & Africa Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 52. Middle East & Africa Daunorubicin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Daunorubicin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 56. Middle East & Africa Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 57. Key Market Drivers & Growth Opportunities of Daunorubicin
Table 58. Key Market Challenges & Risks of Daunorubicin
Table 59. Key Industry Trends of Daunorubicin
Table 60. Daunorubicin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Daunorubicin Distributors List
Table 63. Daunorubicin Customer List
Table 64. Global Daunorubicin Sales Forecast by Region (2024-2029) & (Litre)
Table 65. Global Daunorubicin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 67. Americas Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Daunorubicin Sales Forecast by Region (2024-2029) & (Litre)
Table 69. APAC Daunorubicin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 71. Europe Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 73. Middle East & Africa Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Daunorubicin Sales Forecast by Type (2024-2029) & (Litre)
Table 75. Global Daunorubicin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Daunorubicin Sales Forecast by Application (2024-2029) & (Litre)
Table 77. Global Daunorubicin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Daunorubicin Product Portfolios and Specifications
Table 80. Sanofi Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Halison Pharmaceuiticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 84. Halison Pharmaceuiticals Daunorubicin Product Portfolios and Specifications
Table 85. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 86. Halison Pharmaceuiticals Main Business
Table 87. Halison Pharmaceuiticals Latest Developments
Table 88. Hikma Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 89. Hikma Pharmaceuticals Daunorubicin Product Portfolios and Specifications
Table 90. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 91. Hikma Pharmaceuticals Main Business
Table 92. Hikma Pharmaceuticals Latest Developments
Table 93. Gilead Sciences Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 94. Gilead Sciences Daunorubicin Product Portfolios and Specifications
Table 95. Gilead Sciences Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 96. Gilead Sciences Main Business
Table 97. Gilead Sciences Latest Developments
Table 98. Bedford Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 99. Bedford Pharmaceuticals Daunorubicin Product Portfolios and Specifications
Table 100. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 101. Bedford Pharmaceuticals Main Business
Table 102. Bedford Pharmaceuticals Latest Developments
Table 103. United Biotech Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 104. United Biotech Daunorubicin Product Portfolios and Specifications
Table 105. United Biotech Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 106. United Biotech Main Business
Table 107. United Biotech Latest Developments
Table 108. Mercian Corporation Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 109. Mercian Corporation Daunorubicin Product Portfolios and Specifications
Table 110. Mercian Corporation Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 111. Mercian Corporation Main Business
Table 112. Mercian Corporation Latest Developments
Table 113. Pharmacia Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 114. Pharmacia Daunorubicin Product Portfolios and Specifications
Table 115. Pharmacia Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 116. Pharmacia Main Business
Table 117. Pharmacia Latest Developments
Table 118. Cipla Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 119. Cipla Daunorubicin Product Portfolios and Specifications
Table 120. Cipla Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 121. Cipla Main Business
Table 122. Cipla Latest Developments
Table 123. TEVA Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 124. TEVA Daunorubicin Product Portfolios and Specifications
Table 125. TEVA Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 126. TEVA Main Business
Table 127. TEVA Latest Developments
Table 128. Medior Healthcare Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 129. Medior Healthcare Daunorubicin Product Portfolios and Specifications
Table 130. Medior Healthcare Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 131. Medior Healthcare Main Business
Table 132. Medior Healthcare Latest Developments
Table 133. West-Ward Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 134. West-Ward Daunorubicin Product Portfolios and Specifications
Table 135. West-Ward Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 136. West-Ward Main Business
Table 137. West-Ward Latest Developments
Table 138. Shandong Xinshidai Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolios and Specifications
Table 140. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 141. Shandong Xinshidai Pharmaceutical Main Business
Table 142. Shandong Xinshidai Pharmaceutical Latest Developments
Table 143. HISUN Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 144. HISUN Daunorubicin Product Portfolios and Specifications
Table 145. HISUN Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 146. HISUN Main Business
Table 147. HISUN Latest Developments
Table 148. Shenzhen Wanle Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 149. Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolios and Specifications
Table 150. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 151. Shenzhen Wanle Pharmaceutical Main Business
Table 152. Shenzhen Wanle Pharmaceutical Latest Developments
Table 1. Daunorubicin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Daunorubicin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Drip
Table 5. Global Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 6. Global Daunorubicin Sales Market Share by Type (2018-2023)
Table 7. Global Daunorubicin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Daunorubicin Revenue Market Share by Type (2018-2023)
Table 9. Global Daunorubicin Sale Price by Type (2018-2023) & (US$/Litre)
Table 10. Global Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 11. Global Daunorubicin Sales Market Share by Application (2018-2023)
Table 12. Global Daunorubicin Revenue by Application (2018-2023)
Table 13. Global Daunorubicin Revenue Market Share by Application (2018-2023)
Table 14. Global Daunorubicin Sale Price by Application (2018-2023) & (US$/Litre)
Table 15. Global Daunorubicin Sales by Company (2018-2023) & (Litre)
Table 16. Global Daunorubicin Sales Market Share by Company (2018-2023)
Table 17. Global Daunorubicin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Daunorubicin Revenue Market Share by Company (2018-2023)
Table 19. Global Daunorubicin Sale Price by Company (2018-2023) & (US$/Litre)
Table 20. Key Manufacturers Daunorubicin Producing Area Distribution and Sales Area
Table 21. Players Daunorubicin Products Offered
Table 22. Daunorubicin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Daunorubicin Sales by Geographic Region (2018-2023) & (Litre)
Table 26. Global Daunorubicin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Daunorubicin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Daunorubicin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Daunorubicin Sales by Country/Region (2018-2023) & (Litre)
Table 30. Global Daunorubicin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Daunorubicin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Daunorubicin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 34. Americas Daunorubicin Sales Market Share by Country (2018-2023)
Table 35. Americas Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Daunorubicin Revenue Market Share by Country (2018-2023)
Table 37. Americas Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 38. Americas Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 39. APAC Daunorubicin Sales by Region (2018-2023) & (Litre)
Table 40. APAC Daunorubicin Sales Market Share by Region (2018-2023)
Table 41. APAC Daunorubicin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Daunorubicin Revenue Market Share by Region (2018-2023)
Table 43. APAC Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 44. APAC Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 45. Europe Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 46. Europe Daunorubicin Sales Market Share by Country (2018-2023)
Table 47. Europe Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Daunorubicin Revenue Market Share by Country (2018-2023)
Table 49. Europe Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 50. Europe Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 51. Middle East & Africa Daunorubicin Sales by Country (2018-2023) & (Litre)
Table 52. Middle East & Africa Daunorubicin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Daunorubicin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Daunorubicin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Daunorubicin Sales by Type (2018-2023) & (Litre)
Table 56. Middle East & Africa Daunorubicin Sales by Application (2018-2023) & (Litre)
Table 57. Key Market Drivers & Growth Opportunities of Daunorubicin
Table 58. Key Market Challenges & Risks of Daunorubicin
Table 59. Key Industry Trends of Daunorubicin
Table 60. Daunorubicin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Daunorubicin Distributors List
Table 63. Daunorubicin Customer List
Table 64. Global Daunorubicin Sales Forecast by Region (2024-2029) & (Litre)
Table 65. Global Daunorubicin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 67. Americas Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Daunorubicin Sales Forecast by Region (2024-2029) & (Litre)
Table 69. APAC Daunorubicin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 71. Europe Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Daunorubicin Sales Forecast by Country (2024-2029) & (Litre)
Table 73. Middle East & Africa Daunorubicin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Daunorubicin Sales Forecast by Type (2024-2029) & (Litre)
Table 75. Global Daunorubicin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Daunorubicin Sales Forecast by Application (2024-2029) & (Litre)
Table 77. Global Daunorubicin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Daunorubicin Product Portfolios and Specifications
Table 80. Sanofi Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Halison Pharmaceuiticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 84. Halison Pharmaceuiticals Daunorubicin Product Portfolios and Specifications
Table 85. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 86. Halison Pharmaceuiticals Main Business
Table 87. Halison Pharmaceuiticals Latest Developments
Table 88. Hikma Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 89. Hikma Pharmaceuticals Daunorubicin Product Portfolios and Specifications
Table 90. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 91. Hikma Pharmaceuticals Main Business
Table 92. Hikma Pharmaceuticals Latest Developments
Table 93. Gilead Sciences Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 94. Gilead Sciences Daunorubicin Product Portfolios and Specifications
Table 95. Gilead Sciences Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 96. Gilead Sciences Main Business
Table 97. Gilead Sciences Latest Developments
Table 98. Bedford Pharmaceuticals Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 99. Bedford Pharmaceuticals Daunorubicin Product Portfolios and Specifications
Table 100. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 101. Bedford Pharmaceuticals Main Business
Table 102. Bedford Pharmaceuticals Latest Developments
Table 103. United Biotech Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 104. United Biotech Daunorubicin Product Portfolios and Specifications
Table 105. United Biotech Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 106. United Biotech Main Business
Table 107. United Biotech Latest Developments
Table 108. Mercian Corporation Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 109. Mercian Corporation Daunorubicin Product Portfolios and Specifications
Table 110. Mercian Corporation Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 111. Mercian Corporation Main Business
Table 112. Mercian Corporation Latest Developments
Table 113. Pharmacia Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 114. Pharmacia Daunorubicin Product Portfolios and Specifications
Table 115. Pharmacia Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 116. Pharmacia Main Business
Table 117. Pharmacia Latest Developments
Table 118. Cipla Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 119. Cipla Daunorubicin Product Portfolios and Specifications
Table 120. Cipla Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 121. Cipla Main Business
Table 122. Cipla Latest Developments
Table 123. TEVA Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 124. TEVA Daunorubicin Product Portfolios and Specifications
Table 125. TEVA Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 126. TEVA Main Business
Table 127. TEVA Latest Developments
Table 128. Medior Healthcare Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 129. Medior Healthcare Daunorubicin Product Portfolios and Specifications
Table 130. Medior Healthcare Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 131. Medior Healthcare Main Business
Table 132. Medior Healthcare Latest Developments
Table 133. West-Ward Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 134. West-Ward Daunorubicin Product Portfolios and Specifications
Table 135. West-Ward Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 136. West-Ward Main Business
Table 137. West-Ward Latest Developments
Table 138. Shandong Xinshidai Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolios and Specifications
Table 140. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 141. Shandong Xinshidai Pharmaceutical Main Business
Table 142. Shandong Xinshidai Pharmaceutical Latest Developments
Table 143. HISUN Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 144. HISUN Daunorubicin Product Portfolios and Specifications
Table 145. HISUN Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 146. HISUN Main Business
Table 147. HISUN Latest Developments
Table 148. Shenzhen Wanle Pharmaceutical Basic Information, Daunorubicin Manufacturing Base, Sales Area and Its Competitors
Table 149. Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolios and Specifications
Table 150. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2018-2023)
Table 151. Shenzhen Wanle Pharmaceutical Main Business
Table 152. Shenzhen Wanle Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Daunorubicin
Figure 2. Daunorubicin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daunorubicin Sales Growth Rate 2018-2029 (Litre)
Figure 7. Global Daunorubicin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Daunorubicin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intravenous
Figure 10. Product Picture of Drip
Figure 11. Global Daunorubicin Sales Market Share by Type in 2022
Figure 12. Global Daunorubicin Revenue Market Share by Type (2018-2023)
Figure 13. Daunorubicin Consumed in Acute Granulocyte
Figure 14. Global Daunorubicin Market: Acute Granulocyte (2018-2023) & (Litre)
Figure 15. Daunorubicin Consumed in Acute Lymphocyte Leukemia
Figure 16. Global Daunorubicin Market: Acute Lymphocyte Leukemia (2018-2023) & (Litre)
Figure 17. Global Daunorubicin Sales Market Share by Application (2022)
Figure 18. Global Daunorubicin Revenue Market Share by Application in 2022
Figure 19. Daunorubicin Sales Market by Company in 2022 (Litre)
Figure 20. Global Daunorubicin Sales Market Share by Company in 2022
Figure 21. Daunorubicin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Daunorubicin Revenue Market Share by Company in 2022
Figure 23. Global Daunorubicin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Daunorubicin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Daunorubicin Sales 2018-2023 (Litre)
Figure 26. Americas Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Daunorubicin Sales 2018-2023 (Litre)
Figure 28. APAC Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Daunorubicin Sales 2018-2023 (Litre)
Figure 30. Europe Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Daunorubicin Sales 2018-2023 (Litre)
Figure 32. Middle East & Africa Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Daunorubicin Sales Market Share by Country in 2022
Figure 34. Americas Daunorubicin Revenue Market Share by Country in 2022
Figure 35. Americas Daunorubicin Sales Market Share by Type (2018-2023)
Figure 36. Americas Daunorubicin Sales Market Share by Application (2018-2023)
Figure 37. United States Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Daunorubicin Sales Market Share by Region in 2022
Figure 42. APAC Daunorubicin Revenue Market Share by Regions in 2022
Figure 43. APAC Daunorubicin Sales Market Share by Type (2018-2023)
Figure 44. APAC Daunorubicin Sales Market Share by Application (2018-2023)
Figure 45. China Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Daunorubicin Sales Market Share by Country in 2022
Figure 53. Europe Daunorubicin Revenue Market Share by Country in 2022
Figure 54. Europe Daunorubicin Sales Market Share by Type (2018-2023)
Figure 55. Europe Daunorubicin Sales Market Share by Application (2018-2023)
Figure 56. Germany Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Daunorubicin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Daunorubicin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Daunorubicin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Daunorubicin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Daunorubicin in 2022
Figure 71. Manufacturing Process Analysis of Daunorubicin
Figure 72. Industry Chain Structure of Daunorubicin
Figure 73. Channels of Distribution
Figure 74. Global Daunorubicin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Daunorubicin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Daunorubicin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Daunorubicin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Daunorubicin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Daunorubicin Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Daunorubicin
Figure 2. Daunorubicin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daunorubicin Sales Growth Rate 2018-2029 (Litre)
Figure 7. Global Daunorubicin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Daunorubicin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intravenous
Figure 10. Product Picture of Drip
Figure 11. Global Daunorubicin Sales Market Share by Type in 2022
Figure 12. Global Daunorubicin Revenue Market Share by Type (2018-2023)
Figure 13. Daunorubicin Consumed in Acute Granulocyte
Figure 14. Global Daunorubicin Market: Acute Granulocyte (2018-2023) & (Litre)
Figure 15. Daunorubicin Consumed in Acute Lymphocyte Leukemia
Figure 16. Global Daunorubicin Market: Acute Lymphocyte Leukemia (2018-2023) & (Litre)
Figure 17. Global Daunorubicin Sales Market Share by Application (2022)
Figure 18. Global Daunorubicin Revenue Market Share by Application in 2022
Figure 19. Daunorubicin Sales Market by Company in 2022 (Litre)
Figure 20. Global Daunorubicin Sales Market Share by Company in 2022
Figure 21. Daunorubicin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Daunorubicin Revenue Market Share by Company in 2022
Figure 23. Global Daunorubicin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Daunorubicin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Daunorubicin Sales 2018-2023 (Litre)
Figure 26. Americas Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Daunorubicin Sales 2018-2023 (Litre)
Figure 28. APAC Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Daunorubicin Sales 2018-2023 (Litre)
Figure 30. Europe Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Daunorubicin Sales 2018-2023 (Litre)
Figure 32. Middle East & Africa Daunorubicin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Daunorubicin Sales Market Share by Country in 2022
Figure 34. Americas Daunorubicin Revenue Market Share by Country in 2022
Figure 35. Americas Daunorubicin Sales Market Share by Type (2018-2023)
Figure 36. Americas Daunorubicin Sales Market Share by Application (2018-2023)
Figure 37. United States Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Daunorubicin Sales Market Share by Region in 2022
Figure 42. APAC Daunorubicin Revenue Market Share by Regions in 2022
Figure 43. APAC Daunorubicin Sales Market Share by Type (2018-2023)
Figure 44. APAC Daunorubicin Sales Market Share by Application (2018-2023)
Figure 45. China Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Daunorubicin Sales Market Share by Country in 2022
Figure 53. Europe Daunorubicin Revenue Market Share by Country in 2022
Figure 54. Europe Daunorubicin Sales Market Share by Type (2018-2023)
Figure 55. Europe Daunorubicin Sales Market Share by Application (2018-2023)
Figure 56. Germany Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Daunorubicin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Daunorubicin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Daunorubicin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Daunorubicin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Daunorubicin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Daunorubicin in 2022
Figure 71. Manufacturing Process Analysis of Daunorubicin
Figure 72. Industry Chain Structure of Daunorubicin
Figure 73. Channels of Distribution
Figure 74. Global Daunorubicin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Daunorubicin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Daunorubicin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Daunorubicin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Daunorubicin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Daunorubicin Revenue Market Share Forecast by Application (2024-2029)
